Laboratory for Human Physiology, School of Health Sciences, Univ. of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, 807-8555 Kitakyushu, Japan.
J Appl Physiol (1985). 2010 Feb;108(2):328-33. doi: 10.1152/japplphysiol.00814.2009. Epub 2009 Dec 10.
Local cooling (LC) of nonglabrous skin causes vasoconstriction via the adrenergic and removal of nitric oxide (NO) systems. Since cooling increases reactive oxygen species in smooth muscle cells and induces increased sensitivity of alpha-adrenergic receptors, antioxidant supplementation may attenuate the vasoconstrictor response to skin LC via adrenergic and/or NO systems. To test this hypothesis, we examined the effects of acute L-ascorbate (Asc, 10 mM) supplementation in human skin on the vasoconstrictor responses to LC in skin with and without NO synthase (NOS) inhibition or adrenergic receptor blockade. In a three-part study, forearm sites were instrumented with microdialysis fibers, local coolers, and laser-Doppler flow (LDF) probes in healthy volunteers. Sites were cooled from 34 to 24 degrees C at -1 degrees C/min and maintained at 24 degrees C for 20 min (parts 1 and 2) or 30 min (part 3). During the last 10 min of LC in parts 1 and 2, whole body cooling was performed to increase sympathetic vasoconstrictor activity. Cutaneous vascular conductance (CVC) was calculated as the ratio of LDF to blood pressure and expressed relative to the baseline value before cooling. Treatments in each part were as follows: part 1) untreated, Asc; part 2) N(G)-nitro-L-arginine methyl ester (L-NAME) to inhibit NOS, combined L-NAME + Asc; part 3) yohimbine (YOH) + propranolol (PRO) to antagonize alpha- and beta-adrenergic receptors and combined YOH + PRO + Asc. CVC reduction during LC was smaller (P < 0.001) at Asc sites (-31 +/- 4%) than at untreated sites (-56 +/- 5%). LC-induced reduction in CVC was smaller (P < 0.05) at L-NAME + Asc sites (-23 +/- 8%) than at L-NAME sites (-43 +/- 7%). LC-induced reduction in CVC did not differ between at PRO + YOH sites (-56 +/- 3%) and at PRO + YOH + Asc sites (-50 +/- 3%). These findings suggest that antioxidant supplementation inhibits the vasoconstrictor response to direct cooling through an adrenoceptor-dependent mechanism in human skin.
局部皮肤冷却(LC)通过肾上腺素能和一氧化氮(NO)系统引起血管收缩。由于冷却会增加平滑肌细胞中的活性氧物质,并诱导α-肾上腺素能受体的敏感性增加,抗氧化剂补充可能会通过肾上腺素能和/或 NO 系统减轻皮肤 LC 引起的血管收缩反应。为了验证这一假设,我们研究了急性 L-抗坏血酸(Asc,10mM)补充在人类皮肤中的作用,即在有和没有一氧化氮合酶(NOS)抑制或肾上腺素能受体阻断的情况下,对 LC 引起的血管收缩反应的影响。在一项三部分研究中,健康志愿者在前臂部位安装了微透析纤维、局部冷却器和激光多普勒流量(LDF)探头。在 -1°C/min 的降温速度下将皮肤从 34°C 降至 24°C,并在 24°C 下维持 20 分钟(第 1 和第 2 部分)或 30 分钟(第 3 部分)。在第 1 和第 2 部分的 LC 的最后 10 分钟,进行全身冷却以增加交感神经血管收缩活性。皮肤血管传导率(CVC)被计算为 LDF 与血压的比值,并相对于冷却前的基线值表示。每个部分的处理如下:第 1 部分)未处理,Asc;第 2 部分)N(G)-硝基-L-精氨酸甲酯(L-NAME)抑制 NOS,联合 L-NAME + Asc;第 3 部分)育亨宾(YOH)+普萘洛尔(PRO)拮抗α-和β-肾上腺素能受体,联合 YOH + PRO + Asc。在 Asc 部位,LC 时 CVC 的减少幅度较小(P <0.001)(-31 +/- 4%),而未处理部位的减少幅度较大(-56 +/- 5%)。在 L-NAME + Asc 部位,LC 引起的 CVC 减少幅度较小(P <0.05)(-23 +/- 8%),而在 L-NAME 部位的减少幅度较大(-43 +/- 7%)。在 PRO + YOH 部位和 PRO + YOH + Asc 部位,LC 引起的 CVC 减少幅度无差异(-56 +/- 3%和-50 +/- 3%)。这些发现表明,抗氧化剂补充通过人类皮肤中的肾上腺素能受体依赖性机制抑制直接冷却引起的血管收缩反应。